Whether we're winning or losing against COVID-19 | Marc Lipsitch (2020)

Pandemic Status and Epidemiological Data

• Estimated US infection prevalence is currently in the high single digits overall, though highly variable by location (e.g., ~30% in Chelsea, Massachusetts, versus low single digits in other areas).
• Infection Fatality Rate (IFR) estimates are refined to a range of 0.2% to 1.5%, with a central estimate likely below 1%.
• Most infected individuals appear to develop multi-component immunity (T-cells and antibodies) that likely provides protection against reinfection for at least one to two years.
• Cross-country comparisons (e.g., South Korea, Singapore, India) provide valuable hypotheses for transmission dynamics, though results are complicated by luck, early exposure timing, and unmeasured variables like weather or immunity history.
• The US and UK fared poorly compared to international benchmarks, primarily due to a lack of national strategy, delayed testing implementation, and political prioritization over scientific advice.
• The US travel ban from China was a tactical gesture rather than a strategic component; it failed to prevent spread because it was not paired with capacity building for PPE, hospital surge, and testing.

Policy Critiques and Recommendations

• Modeling Errors: The IHME curve-fitting model was criticized for lacking infectious disease dynamics; a JAMA paper by Pan et al. was criticized for methodological flaws that erroneously suggested only involuntary family separation could control outbreaks.
• Contact Tracing Limitations: Contact tracing is ineffective during high-incidence phases (like early NY) when most cases are undetected; it is better suited for low-incidence periods or as part of a broader strategy.
• Outdoor Spaces: Closing outdoor public spaces (parks, beaches) is counterproductive for mental health and public compliance, as outdoor transmission risk is significantly lower than indoors.
• Sweden's Approach: Sweden's laissez-faire strategy resulted in higher mortality than neighbors, demonstrating that uncoordinated social distancing is costly, though natural self-isolation by citizens mitigated some economic damage.
• Testing Strategy: All viable reopening plans require massive scaling of testing; the primary limitation is not technical but infrastructural (supply chains and reagent availability).
• Surveillance: Randomized population-wide testing (serosurveys) is critical for understanding true spread and IFR, but requires specific infrastructure (e.g., census agencies) to avoid bias.
• Human Challenge Trials: Mark Lipsitch advocates for ethical human challenge trials to accelerate vaccine development, arguing that the high social value outweighs the low risk to willing, healthy volunteers.
• Drug Development: Funding should shift toward antiviral drugs for early/mild infection to prevent severe disease and reduce hospital burden, rather than focusing solely on late-stage treatments.

Future Preparedness and Field Development

• Ecosystem Dependency: The ability to respond to pandemics relies on a "peacetime" ecosystem of researchers studying diverse diseases (flu, dengue, cholera) who can pivot quickly.
• Funding Cuts: Key infrastructure programs (MIDAS, RAPID, Summer Institutes) have lost funding, threatening the pipeline of trained epidemiologists and methodologists.
• Grant System Reform: The current NIH grant cycle (taking ~15 months) is too slow for rapidly evolving threats; funding models need to shift toward faster, flexible, peer-reviewed group funding rather than rigid project-based grants.
• Data Challenges: The field must improve methods for "now-casting," back-calculation, and handling messy, changing data (e.g., shifting testing capacity), rather than seeking "perfect" data.
• Expert Reliability: Credible expertise is correlated with long-term experience in the field, transparency about uncertainty, and the ability to explain models clearly to non-experts.
• Crowd Forecasting: While crowdsourced forecasts can be accurate, comparing them to expert surveys is often "apples to oranges" due to differences in effort, time pressure, and aggregation algorithms.

Career Advice for Effective Altruists

• Skill Development: Students should focus on quantitative fields that integrate data literacy with an appreciation for the "messiness" of real-world epidemiological data.
• Institutional Choice: Top programs include Harvard Chan School, London School of Hygiene & Tropical Medicine, Imperial College, University of Hong Kong, Princeton, and the University of Chicago.
• Motivation: Effective contributors should pursue work that aligns with their genuine interests to ensure long-term engagement, rather than focusing solely on perceived "high impact" areas that may lead to burnout.
• Public Contribution: Non-experts can contribute by summarizing evidence accurately, avoiding misinformation, and supporting leaders who respect scientific evidence.

Other Announcements

• EAGx Virtual: The Effective Altruism Global conference was cancelled; a new online event (June 12–14) is scheduled with a pay-as-you-want model (suggested $40) to facilitate networking and content sharing.
• WEBSITE: Lipsitch's team maintains covidpathforward.com, outlining 14 consensus points for pandemic policy, including testing scale-ups, mask usage, and healthier building ventilation.